Friday - October 02, 2026

Category Archives: Science

New 20-Part YouTube Series “Forbidden Archaeology: The Lost Civilizations of the Deep Past” Launches to Challenge Everything You Know About Human History

The official series artwork for “Forbidden Archaeology: The Lost Civilizations of the Deep Past” — a 20-part YouTube documentary series exploring ancient mysteries and hidden histories that mainstream science has long overlooked. A groundbreaking 20-part YouTube documentary series, “Forbidden Archaeology: … Continue reading →

Closing the Imaging Access Gap in Canada’s Rural Healthcare System – Perspective from Hugo Raposo, Former Chief Architect at the Ontario Ministry of Health

Access to life-saving diagnostics should never depend on a patient’s postal code. Technology now gives us the ability to bring advanced imaging expertise to every community—no matter how remote. Editorial by Samantha Di Khali, Khali Comunica — Former Ontario Ministry … Continue reading →

Advanced Cervical Cancer Treatment Pipeline Shows Strong Momentum as 70+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Advanced Cervical Cancer Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Advanced Cervical Cancer pipeline landscape. It covers the Advanced Cervical Cancer pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Acute Respiratory Distress Syndrome Clinical Trial Pipeline Expands as 50+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Acute Respiratory Distress Syndrome Pipeline Insights 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Acute Respiratory Distress Syndrome pipeline landscape. It covers the Acute Respiratory Distress Syndrome pipeline drug profiles, including clinical and nonclinical … Continue reading →

Wet-AMD Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight

DelveInsight’s “Wet-AMD Pipeline Insight 2026” report provides comprehensive insights about 60+ companies and 75+ pipeline drugs in the Wet-AMD pipeline landscape. It covers the Wet-AMD Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Wet-AMD Pipeline … Continue reading →

T-Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 90+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “T-Cell Lymphoma Pipeline Insight, 2026” report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in T-Cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment … Continue reading →

Global Cancer Biomarkers Market to Reach $42.0 Billion by 2029

Cancer Biomarkers Market by Profiling Technology (Omics, Imaging), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Product (Instruments, Consumables), Application (Diagnostics, R&D, Prognostics), End-user, and Region – Global Forecast to 2029 According to MarketsandMarkets™, The report “Cancer Biomarkers Market by Profiling Technology … Continue reading →

Ulcerative Colitis Treatment Pipeline Shows Strong Momentum as 70+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Ulcerative Colitis Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Ulcerative Colitis Pipeline Landscape. It covers the Ulcerative Colitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →